test

Nir Messafi

@Deep Track Capital, Lp

Latest period2024 - Q3ReportedManaged Assets$3.153BTotal holdings69
Assets growth rate-5.9%Assets growth rate (2-Q avg)-4.96%Continuous growth in asset value0 quarters

Portfolio positions

This chart displays the top 10 holdings in Deep Track Capital, Lp's 2024 - Q3 portfolio, based on their 13F SEC filing, out of a total of 69 positions.

Assets under management

The assets under management (AUM) of Deep Track Capital, Lp over the past 10 years (40 quarters) show continuous growth in total asset value over the last 0 quarters. As of the latest 13F SEC filing for 2024 - Q3, they manage 3.153B in assets, with a quarterly growth rate of -5.9% and a 2-quarter average growth rate of -4.96%. The portfolio is managed by Nir Messafi, and others.

Portfolio holdings

CurrentNew PositionIncreasedDecreasedExited
InvestmentPortfolio %Reported Value
DVAXDynavax Technologies Corp
Recent Activity
Increased 14.93%
4.43%
$139.545M
12.526M shares@ $11.14 avg price
GHGuardant Health Inc
Recent Activity
Increased 33.35%
4.37%
$137.653M
6.001M shares@ $22.94 avg price
APLSApellis Pharmaceuticals Inc
Recent Activity
Increased 76.03%
4.03%
$126.915M
4.401M shares@ $28.84 avg price
IMVTImmunovant Inc
Recent Activity
Increased 50.76%
3.94%
$123.946M
4.347M shares@ $28.52 avg price
SWTXSpringworks Therapeutics Inc
Recent Activity
Increased 3.89%
3.91%
$123.159M
3.844M shares@ $32.04 avg price
ITCIIntra-cellular Therapies Inc
Recent Activity
Increased 4.09%
3.72%
$117.123M
1.601M shares@ $73.18 avg price
NTLAIntellia Therapeutics Inc
Recent Activity
Increased 3.13%
3.23%
$101.722M
4.95M shares@ $20.55 avg price
IONSIonis Pharmaceuticals Inc
Recent Activity
Increased 10%
2.8%
$88.132M
2.2M shares@ $40.06 avg price
BCYCBicycle Therapeutics Plc
Recent Activity
Increased 1.65%
2.55%
$80.291M
3.548M shares@ $22.64 avg price
GPCRStructure Therapeutics Inc
Recent Activity
Increased 28.48%
1.7%
$53.568M
1.221M shares@ $43.89 avg price